Orally Deliverable Iron‐Ceria Nanotablets for Treatment of Inflammatory Bowel Disease
Advanced Healthcare Materials · 2025-03 · 14 (8)
DOI: 10.1002/adhm.202401994 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 05.09.2024. Verfasst von Seungmin Baik und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical and Biological Engineering and Institute of Chemical Process, Seoul National University, Seoul, 08826, Republic of Korea. Hauptthemen laut MEDLINE: Inflammatory Bowel Diseases, Iron, Cerium, Nanoparticles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Institute for Basic Science, Ministry of Science and ICT, Ministry of Science and ICT, South Korea.
Abstract (Originalsprache)
Ceria‐based nanoparticles are versatile in treating various inflammatory diseases, but their feasibility in clinical translation is undermined by safety concerns and a limited delivery system. Meanwhile, the idiopathic nature of inflammatory bowel disease (IBD) calls for a wider variety of therapeutics via moderation of the intestinal immune system. In this regard, the synthesis and oral formulation of iron‐ceria nanoparticles (CF NPs) with enhanced nanozymic activity and lower toxicity risk than conventional ceria‐based nanoparticles are reported. CF NPs are clustered in calcium phosphate (CaP) and coated with a pH‐responsive polymer to provide the enteric formulation of iron‐ceria nanotablets (CFNT). CFNT exhibits a marked alleviative efficacy in the dextran sodium sulfate (DSS)‐induced enterocolitis model in vivo by modulating the pro‐inflammatory behavior of innate immune cells including macrophages and neutrophils, promoting anti‐inflammatory cytokine profiles, and downregulating key transcription factors of inflammatory pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical and Biological Engineering and Institute of Chemical Process, Seoul National University, Seoul, 08826, Republic of Korea.
- Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul, 08826, Republic of Korea.
- Department of Neurology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, 08308, Republic of Korea.
- Department of Medical Science, BK21 Plus KUMS Graduate Program, Korea University College of Medicine, Seoul, 08308, Republic of Korea.
- Department of Radiology, Seoul National University College of Medicine, Seoul, 03080, Republic of Korea.
- Bio-MAX Institute, Seoul National University, Seoul, 08826, Republic of Korea.
ORCID-Profile: Seungmin Baik, Hyunmin Kim, Yunjung Lee, Taegyu Kang, Kwangsoo Shin, Ok Kyu Park, Byeonggeun Kang, Nohyun Lee, Dokyoon Kim, Seung Hong Choi, Seung Han Kim, Min Soh, Taeghwan Hyeon, Chi Kyung Kim
Förderung
- Institute for Basic Science
- Ministry of Science and ICT
- Ministry of Science and ICT, South Korea
Zitieren
APA
Baik, S., Kim, H., Lee, Y., Kang, T., Shin, K., Song, C., Park, O. K., Kang, B., Lee, N., Kim, D., Choi, S. H., Kim, S. H., Soh, M., Hyeon, T., & Kim, C. K. (2025). Orally Deliverable Iron‐Ceria Nanotablets for Treatment of Inflammatory Bowel Disease. Advanced Healthcare Materials, 14(8). https://doi.org/10.1002/adhm.202401994
Vancouver
Baik S, Kim H, Lee Y, Kang T, Shin K, Song C, et al. Orally Deliverable Iron‐Ceria Nanotablets for Treatment of Inflammatory Bowel Disease. Advanced Healthcare Materials. 2025;14(8). doi:10.1002/adhm.202401994
BibTeX
@article{Baik2025,
author = {Baik, Seungmin and Kim, Hyunmin and Lee, Yunjung and Kang, Taegyu and Shin, Kwangsoo and Song, Changyeong and Park, Ok Kyu and Kang, Byeonggeun and Lee, Nohyun and Kim, Dokyoon and Choi, Seung Hong and Kim, Seung Han and Soh, Min and Hyeon, Taeghwan and Kim, Chi Kyung},
title = {Orally Deliverable Iron‐Ceria Nanotablets for Treatment of Inflammatory Bowel Disease},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {8},
doi = {10.1002/adhm.202401994}
}
EUVIMED